How reliable are AI virtual cells compared with experimental models? We examine what each can predict or measure, the ...
How can multiomics help researchers identify more promising drug targets? Dr Shi-qi An explores how combining molecular data ...
Researchers have identified a transporter protein that could enable creatine derivatives and other therapeutic compounds to ...
A bispecific antibody targeting CCR8 and CD3 has demonstrated the ability to deplete immunosuppressive regulatory T cells and ...
High affinity is often a priority when selecting reagents, but does it guarantee better assay performance? Discover why ...
A new review of primary biliary cholangitis reveals how interactions between bile duct epithelial cells and immune ...
Could targeting SRC-3 in regulatory T cells help overcome tumour immunosuppression? Researchers explain how this approach ...
Researchers have discovered a new family of bacterial natural products that bind the cancer-associated enzyme AKR1C3, ...
Aptamers can recognise cancer-associated targets and deliver drugs directly to tumour cells. So why have so few reached the ...
Dr David Lonard is Chief Scientific Officer at CoRegen and Professor of Molecular and Cellular Biology at Baylor College of Medicine, where he co-directs the Center for Coregulator Research. He has ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results